Assessment of clinicopathological features, evaluation of treatment, and prognosis of clear cell and serous papillary endometrial carcinoma

ArticleAçık Erişim

Özet

Objectives: We aimed to evaluate and compare the clinical and pathological features, diagnosis, treatment, and prognosis of uterine papillary serous carcinoma (UPSC) and clear-cell carcinoma (CC). Material and methods: Thirty-four patients who were operated on for UPSC and CC carcinoma at the Izmir Tepecik Research and Teaching Hospital, between January 1983 and December 2014, were included. Patients were evaluated for the following factors: Age, gravidity, parity, preoperative CA-125, tumor size, myometrial and lymphovascular invasion, lymph node tumor metastasis, presence of atypical cells in peritoneal cytology, pathology results, operation types, whether or not they received postoperative adjuvant therapy, prognosis, and death rate. Results: The stage of the disease was the main factor affecting disease-free and the overall survival. Cisplatin-based chemotherapy was partially effective in patients with postoperative recurrence, while postoperative adjuvant radiotherapy proved to be more effective in preventing relapse. Conclusion: The studied parameters generally were concordant with the literature but, due to the relatively small sample size, more comprehensive and multicenter studies are needed to generate valid results. © 2016 Via Medica.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15440Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5603/gp.2016.0046Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKulhan, Mehmet
dc.contributor.authorKulhan, Gozde
dc.contributor.authorNayki, Umit
dc.contributor.authorNayki, Cenk
dc.contributor.authorUlug, Pasa
dc.contributor.authorSipahi, Mehmet
dc.contributor.authorYildirim, Yusuf
dc.date.accessioned2026-10-18T20:30:16.883159581Z
dc.date.available2026-10-18T20:30:16.883159581Z
dc.date.issued2016
dc.description.abstractObjectives: We aimed to evaluate and compare the clinical and pathological features, diagnosis, treatment, and prognosis of uterine papillary serous carcinoma (UPSC) and clear-cell carcinoma (CC). Material and methods: Thirty-four patients who were operated on for UPSC and CC carcinoma at the Izmir Tepecik Research and Teaching Hospital, between January 1983 and December 2014, were included. Patients were evaluated for the following factors: Age, gravidity, parity, preoperative CA-125, tumor size, myometrial and lymphovascular invasion, lymph node tumor metastasis, presence of atypical cells in peritoneal cytology, pathology results, operation types, whether or not they received postoperative adjuvant therapy, prognosis, and death rate. Results: The stage of the disease was the main factor affecting disease-free and the overall survival. Cisplatin-based chemotherapy was partially effective in patients with postoperative recurrence, while postoperative adjuvant radiotherapy proved to be more effective in preventing relapse. Conclusion: The studied parameters generally were concordant with the literature but, due to the relatively small sample size, more comprehensive and multicenter studies are needed to generate valid results. © 2016 Via Medica.
dc.identifier.doi10.5603/gp.2016.0046
dc.identifier.endpage574
dc.identifier.issn0017-0011
dc.identifier.issue8
dc.identifier.pmid27629131
dc.identifier.scopus2-s2.0-84987984221
dc.identifier.startpage570
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15440
dc.identifier.volume87
dc.identifier.wosWOS:000384311200006
dc.language.isoen
dc.publisherStudio K Krzysztof Molenda
dc.relation.ispartofGinekologia Polska
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectClear-cell carcinoma
dc.subjectEndometrial tumors
dc.subjectPapillary cell carcinoma
dc.subjectAdenocarcinoma, Clear Cell
dc.subjectAdult
dc.subjectAged
dc.subjectAntineoplastic Combined Chemotherapy Protocols
dc.subjectCA-125 Antigen
dc.subjectCarcinoma, Papillary
dc.subjectEndometrial Neoplasms
dc.subjectFemale
dc.subjectGravidity
dc.subjectHumans
dc.subjectLymphatic Metastasis
dc.subjectMiddle Aged
dc.subjectNeoplasm Invasiveness
dc.subjectNeoplasm Recurrence, Local
dc.subjectParity
dc.subjectRadiotherapy, Adjuvant
dc.subjectSurvival Analysis
dc.subjectantineoplastic agent
dc.subjectCA 125 antigen
dc.subjectadenocarcinoma
dc.subjectadjuvant radiotherapy
dc.subjectblood
dc.subjectdrug therapy
dc.subjectendometrium tumor
dc.subjecthuman
dc.subjectlymph node metastasis
dc.subjectmortality
dc.titleAssessment of clinicopathological features, evaluation of treatment, and prognosis of clear cell and serous papillary endometrial carcinoma
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus6
rdl.citation.wos6
rdl.departmentTepecik Obstetrics and Gynaecology Training and Research Hospital, Obstetrics and Gynaecology Unit, Izmir, Turkey Erzincan University Medical Faculty, Gynaecology and Obstetrics Department, Erzincan, Turkey. mehmet_kulhan@yahoo.com.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)